Table of Contents
Australian shares presented a mixed performance today, with gains in healthcare adn tech sectors partially offsetting a decline in other areas. Meanwhile, New Zealand’s benchmark index climbed, fueled by expectations of potential interest rate cuts following a contraction in the country’s economy.
Australian Market Performance
The S&P/ASX 200 index fluctuated throughout the day, ultimately closing up 0.1%. Despite the daily gain, the index is on track for its weakest weekly performance in two months, down 1.2% for the week. [^1]
Sector Breakdown:
* Healthcare: Led the gains, rising 2% and poised for its best day in nearly two months. [^2] telix Pharmaceuticals surged as much as 9.7% after receiving a “Buy” rating from Citi. [^3] CSL, a major biotech firm, also saw important gains, climbing as much as 2.5%. [^4]
* Technology: Rose as much as 2.7%, hitting a record high following positive overnight performance in Wall Street indices. The tech sub-index is set for its second consecutive weekly gain, up 1.8% so far. [^5] Xero and Life360, key players in the sector, advanced by 3.6% and 4.3% respectively. [^6]
* Real Estate & Energy: Both sectors experienced modest gains, increasing by 0.5% and 0.6% respectively. [^7]
* Other Sectors: Performance details for other sectors were not provided in the source material.
New Zealand Market Performance
New Zealand’s S&P/NZX 50 index rose 0.7% to 13,210.01. [^8] This increase comes as markets anticipate potential rate cuts by the Reserve Bank of New Zealand. The New Zealand economy contracted by 0.9% in the June quarter, exceeding analysts’ forecasts of a 0.3% decline. [^9] Markets are currently pricing in a 31 basis point reduction in interest rates by October. [^10]
Key Takeaways
* Australian shares showed mixed performance with healthcare and tech leading gains.
* The ASX 200 is facing its worst week in two months.
* New Zealand’s market rose on expectations of rate cuts following a larger-than-expected economic contraction.
* Telix Pharmaceuticals and CSL were key drivers of gains in the Australian healthcare sector.
Looking Ahead
Investors will be closely watching upcoming economic data releases and central bank announcements in both Australia and New Zealand for further clues about the future direction of the markets. The potential for interest rate adjustments will likely continue to be a major factor influencing investor sentiment.
^1]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/
^2]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/
^3]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/
^4]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/
^5]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/
[^6]: [https://www.reuters.com/markets/australian-shares-rise-healthcare-boosts-2024-09-19/](https://www.reuters.com/